Issue Date: December 5, 2011
Before The Storm
The year in pharmaceuticals closes with a milestone event: Pfizer’s Lipitor, the most profitable drug of all time, went off patent last month, delivering the biggest thunderbolt in the storm of patent expirations. The number of drugs losing patent protection will reach a record high in 2012, marking the appearance of the long-anticipated patent cliff.
But after struggling in recent years to reignite lagging product development pipelines, major pharmaceutical companies will ride over . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society